OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SARS-CoV-2 Monoclonal Antibody Treatment Followed by Vaccination Shifts Human Memory B-Cell Epitope Recognition, Suggesting Antibody Feedback
Nathaniel I. Bloom, Sydney I. Ramirez, Hallie Cohn, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 5, pp. 1187-1196
Open Access | Times Cited: 5
Nathaniel I. Bloom, Sydney I. Ramirez, Hallie Cohn, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 5, pp. 1187-1196
Open Access | Times Cited: 5
Showing 5 citing articles:
Sotrovimab: A Review of Its Efficacy against SARS-CoV-2 Variants
Daniele Focosi, Arturo Casadevall, Massimo Franchini, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 217-217
Open Access | Times Cited: 20
Daniele Focosi, Arturo Casadevall, Massimo Franchini, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 217-217
Open Access | Times Cited: 20
Antibody modulation of B cell responses—Incorporating positive and negative feedback
Jason G. Cyster, Patrick C. Wilson
Immunity (2024) Vol. 57, Iss. 7, pp. 1466-1481
Closed Access | Times Cited: 14
Jason G. Cyster, Patrick C. Wilson
Immunity (2024) Vol. 57, Iss. 7, pp. 1466-1481
Closed Access | Times Cited: 14
Development of antiviral drugs for COVID-19 in 2025: unmet needs and future challenges
Daniele Focosi, David J. Sullivan, Massimo Franchini
Expert Review of Anti-infective Therapy (2025)
Closed Access
Daniele Focosi, David J. Sullivan, Massimo Franchini
Expert Review of Anti-infective Therapy (2025)
Closed Access
Tixagevimab/Cilgavimab for COVID-19 Pre-Exposure Prophylaxis in Hematologic Patients—A Tailored Approach Based on SARS-CoV-2 Vaccine Response
Krischan Braitsch, Samuel Jeske, Jacob Stroh, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 871-871
Open Access | Times Cited: 1
Krischan Braitsch, Samuel Jeske, Jacob Stroh, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 871-871
Open Access | Times Cited: 1
Monoclonal antibodies against the spike protein alter the endogenous humoral response to SARS-CoV-2 vaccination and infection
Christopher D. Petro, Andrea T. Hooper, Avery Peace, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 772
Closed Access | Times Cited: 1
Christopher D. Petro, Andrea T. Hooper, Avery Peace, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 772
Closed Access | Times Cited: 1
